87 related articles for article (PubMed ID: 15268803)
1. [Interaction effect of p53 with HBV in hepatoma cell line SMMC-7721].
Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):403-5. PubMed ID: 15268803
[TBL] [Abstract][Full Text] [Related]
2. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
[TBL] [Abstract][Full Text] [Related]
3. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
Lin J; Zhu MH; Qu JH; Li FM; Ni CR
Ai Zheng; 2004 Jul; 23(7):749-55. PubMed ID: 15248906
[TBL] [Abstract][Full Text] [Related]
4. Effects of hepatitis B virus on p53 expression in hepatoma cell line SMMU-7721.
Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
World J Gastroenterol; 2005 Oct; 11(39):6212-5. PubMed ID: 16273653
[TBL] [Abstract][Full Text] [Related]
5. HBV DNA can bind to P53 protein and influence p53 transactivation in hepatoma cells.
Qu J; Lin J; Zhang S; Zhu Z; Ni C; Zhang S; Gao H; Zhu M
Biochem Biophys Res Commun; 2009 Aug; 386(3):504-9. PubMed ID: 19540192
[TBL] [Abstract][Full Text] [Related]
6. [Hepatitis B virus X protein inhibits hepatoma cell growth in vitro through p14(ARF)-dependent and p14(ARF)-independent pathways].
Yu DH; Lin J; Qu JH; Zhu Z; Li FM; Ni CR; Zhu MH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1089-93. PubMed ID: 19726330
[TBL] [Abstract][Full Text] [Related]
7. [Biological impact of the COOH-terminal 40 amino acid deletions of hepatitis B virus X protein in hepatocellular carcinoma cells].
Liu XH; Lin J; Cao XZ; Zheng JM; Chen Y; Zhu MH
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):825-30. PubMed ID: 15949399
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma.
Henkler F; Waseem N; Golding MH; Alison MR; Koshy R
Cancer Res; 1995 Dec; 55(24):6084-91. PubMed ID: 8521397
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF
Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of HBV DNA replication and expression in 2.2.15 hepatoma cells infected with AFP-mediated HBX antisense RNA].
Ma CH; Sun WS; Liu SX; Wang XY; Zhang LN; Cao YL; Han LH
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):291-4. PubMed ID: 12773245
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
[TBL] [Abstract][Full Text] [Related]
12. [Transcriptional inhibitory effect of hepatitis B virus X protein on the expression of p53 tumor suppression gene].
Li J; Liu Y; Dai JZ; Xu DP; Zhang LX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):26-9. PubMed ID: 16642213
[TBL] [Abstract][Full Text] [Related]
13. Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation.
Zhang H; Shan CL; Li N; Zhang X; Zhang XZ; Xu FQ; Zhang S; Qiu LY; Ye LH; Zhang XD
Acta Pharmacol Sin; 2008 Apr; 29(4):473-80. PubMed ID: 18358094
[TBL] [Abstract][Full Text] [Related]
14. [The inhibitory effects on hepatitis B virus replication by stable expression of DN mutants of hepatitis B virus X gene pRev X-GFP].
Song JW; Lin JS; Kong XJ; Liang KH
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):392-4. PubMed ID: 15268799
[TBL] [Abstract][Full Text] [Related]
15. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
16. [The role of hepatitis B virus X gene and p53 on hepatocellular carcinoma cell growth].
Lin J; Zhu MH; Zhu S; Qu JH; Li FM; Ni CR
Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):43-7. PubMed ID: 12760803
[TBL] [Abstract][Full Text] [Related]
17. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
Huang YQ; Wang LW; Yan SN; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
[TBL] [Abstract][Full Text] [Related]
18. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
19. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells.
Zhang X; Dong N; Zhang H; You J; Wang H; Ye L
J Lab Clin Med; 2005 Feb; 145(2):98-104. PubMed ID: 15746653
[TBL] [Abstract][Full Text] [Related]
20. p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells.
Puisieux A; Ponchel F; Ozturk M
Oncogene; 1993 Feb; 8(2):487-90. PubMed ID: 8381223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
